Reappraisal of the Use of Procarbazine in the Treatment of Lymphomas and Brain Tumors

Therapeutics and Clinical Risk Management - New Zealand
doi 10.2147/tcrm.2007.3.2.213
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Lack of Treatment-Related Mortality Definitions in Clinical Trials of Children, Adolescents and Young Adults With Lymphomas, Solid Tumors and Brain Tumors: A Systematic Review

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors

Neurotherapeutics
NeurologyPharmacology
2017English

Modeling the Laser Thermal Therapy in Treatment of Brain Tumors

International Journal of Computer Theory and Engineering
2017English

Constitutional Approach to the Treatment of Patients With Brain Tumors

Siberian Medical Review
2013English

Quality of Randomized Controlled Trials Reporting in the Primary Treatment of Brain Tumors

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Thalamic Tumors in Children: A Reappraisal

Journal of Neurosurgery: Pediatrics
Child HealthPerinatologyNeurologyMedicinePediatricsSurgery
2007English

Critical Appraisal of Temozolomide Formulations in the Treatment of Primary Brain Tumors: Patient Considerations

Cancer Management and Research
Oncology
2009English

Possibilities of Using Cryosurgical Method in Treatment of Depth Brain Tumors

Grekov's Bulletin of Surgery
2016English

Pharmovigilance of Rituximab Biosimilar in the Treatment of Lymphomas in Argentina

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy